(Q45738881)

15 December 2017

Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection (English)

1 reference

15 December 2017

Nass PH

1

1 reference

15 December 2017

Elkins KL

series ordinal

2

1 reference

15 December 2017

Weir JP

series ordinal

3

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

15 December 2017

1 reference

15 December 2017

19

1 reference

15 December 2017

11-12

1 reference

15 December 2017

1538-1546

1 reference

Reinfection is an Uncommon Occurrence in Patients with Symptomatic Recurrent Genital Herpes

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Tipping the scales of herpes simplex virus reactivation: the important responses are local

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Herpes simplex virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

DNA immunization against experimental genital herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

1 reference

7 January 2021

Genetic immunization: a new era in vaccines and immune therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Protection against mycoplasma infection using expression-library immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Herpetic keratitis in athymic (nude) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Pathogenesis of Herpes Simplex Virus in Congenitally Athymic Mice: the Relative Roles of Cell-mediated and Humoral Immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Resistance to herpetic stromal keratitis in immunized B-cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

Mice lacking MHC class II molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900380-7

7 January 2021

10.1016/S0264-410X(00)00380-7

Identifiers

DOI

1 reference

15 December 2017

1 reference